Perritt Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Perritt Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3	Closed	-$1.49K	–	362
2025 Q1	$1.49K	Buy	+3	New	+$1.63K	﹤0.01%	321
2023 Q4	–	Sell	-2	Closed	-$1.01K	–	353
2023 Q3	$1.01K	Buy	+2	New	+$1.07K	﹤0.01%	308

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Perritt Capital Management's TMO Position: Q2 2025 in Review

Perritt Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 3 shares — an estimated $1.49K sold.

Perritt Capital Management first reported a position in TMO in Q3 2023 and held it in 2 quarters. The position peaked at $1.49K in Q1 2025. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Perritt Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Perritt Capital Management sold 3 Thermo Fisher Scientific shares in Q2 2025, an estimated $1.49K.
Perritt Capital Management first reported a position in Thermo Fisher Scientific in Q3 2023 and held it in 2 quarters.
Perritt Capital Management's Thermo Fisher Scientific position peaked at $1.49K in Q1 2025.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Perritt Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.